Entity

Time filter

Source Type

Murviel-lès-Montpellier, France

Barat-Houari M.,Laboratory of Rare and Autoinflammatory Diseases | Barat-Houari M.,French Institute of Health and Medical Research | Sarrabay G.,Laboratory of Rare and Autoinflammatory Diseases | Sarrabay G.,French Institute of Health and Medical Research | And 10 more authors.
Human Mutation | Year: 2016

Mutations in the COL2A1 gene cause a spectrum of rare autosomal-dominant conditions characterized by skeletal dysplasia, short stature, and sensorial defects. An early diagnosis is critical to providing relevant patient care and follow-up, and genetic counseling to affected families. There are no recent exhaustive descriptions of the causal mutations in the literature. Here, we provide a review of COL2A1 mutations extracted from the Leiden Open Variation Database (LOVD) that we updated with data from PubMed and our own patients. Over 700 patients were recorded, harboring 415 different mutations. One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats of the alpha 1 chain. These mutations disrupt the collagen triple helix and are common in achondrogenesis type II and hypochondrogenesis. The mutations resulting in a premature stop codon are found in less severe phenotypes such as Stickler syndrome. The p.(Arg275Cys) substitution is found in all patients with COL2A1-associated Czech dysplasia. LOVD-COL2A1 provides support and potential collaborative material for scientific and clinical projects aimed at elucidating phenotype-genotype correlation and differential diagnosis in patients with type II collagenopathies. © 2016 Wiley Periodicals, Inc. Source

Discover hidden collaborations